FIELD: biotechnologies.
SUBSTANCE: expression vector includes: (a) replication origin OriP obtained from Epstein-Barr virus (EBV), where replication origin contains: 1) symmetry element of the second order (DS); and 2) duplication section (FR) that contains fixation point EBNA; (b) replication origin SV40; (c) insertion section for inserting a gene of concern; (d) promoter EF-1b functionally bound to the insertion section; (e) poly-A signal; (f) bacterial replication origin; (g) selected marker; and unnecessarily containing (h) sequence of nucleic acid, which codes constant area of heavy or light chain of antibody, which is functionally bound to the insertion section. With that, replication origin OriP is bound to an initiation factor of replication EBNA 1, which acts from outside and is not coded with an expression vector.
EFFECT: use of an expression vector in an extracted host cell, a set and a method for obtaining recombinant protein provides production of abundant protein expression.
26 cl, 25 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGONIST NOTCH3 ANTIBODIES AND APPLICATION THEREOF FOR TREATING NOTCH3-ASSOCIATED DISEASES | 2007 |
|
RU2461569C2 |
NEW ANTIBODY TO TSLP-RECEPTOR OF HUMAN | 2014 |
|
RU2689528C2 |
EXPRESSION VECTOR ELEMENT COMBINATION, NEW METHODS FOR OBTAINING PRODUCER CELLS AND THEIR APPLICATION FOR RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2012 |
|
RU2639519C2 |
UNIVERSAL INTEGRATION VECTOR SB7G_HIGH AND RECOMBINANT PLASMID SB7G_HIGH_DEV_57, PROVIDING SYNTHESIS AND SECRETION OF RECOMBINANT HUMAN ANTIBODY TO RECEPTOR-BINDING DOMAIN (RBD) OF CORONAVIRUS SARS-CoV-2 IN MAMMALIAN CELLS AND OBTAINED USING UNIVERSAL VECTOR SB7G_HIGH, AND RECOMBINANT MONOCLONAL ANTIBODY DEV_K57, HAVING VIRUS-NEUTRALIZING ACTIVITY ON SARS-CoV-2 | 2023 |
|
RU2829359C1 |
BIVALENT BISPECIFIC ANTIBODIES | 2008 |
|
RU2587616C2 |
MONOCLONAL ANTIBODY TO IL-5RΑ | 2017 |
|
RU2698048C2 |
ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) | 2008 |
|
RU2514148C2 |
BIVALENT BISPECIFIC ANTIBODIES | 2008 |
|
RU2575066C2 |
COMBINATIONS OF EXPRESSION VECTOR ELEMENTS, NEW METHODS FOR PRODUCING PRODUCER CELLS AND THEIR APPLICATION FOR RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2012 |
|
RU2756910C2 |
ANTIBODIES-ANTAGONISTS AGAINST Notch3 AND THEIR APPLICATION FOR PREVENTION AND TREATMENT OF Notch3-RELATED DISEASES | 2007 |
|
RU2493167C2 |
Authors
Dates
2013-12-27—Published
2009-01-15—Filed